Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06440473
PHASE4

Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin

Sponsor: Rao Dermatology

View on ClinicalTrials.gov

Summary

The goal of this study is to visualize the deposition of topical 0.3% roflumilast (Zoryve) compared to vehicle using Line-Field Optical Coherence Tomography (LC-OCT) in vivo in healthy skin. We hypothesize that the application of topical 0.3% roflumilast (Zoryve) will result in distinct patterns of deposition within the epidermal and dermal layers compared to the vehicle. Specifically, we anticipate observing deeper penetration and more uniform distribution of roflumilast within the skin layers, indicative of enhanced efficacy, as visualized by LC-OCT imaging.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

3

Start Date

2024-05-28

Completion Date

2024-07-28

Last Updated

2024-06-03

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Roflumilast

Roflumilast 0.3% cream

OTHER

Vehicle (Roflumilast 0.3% vehicle cream)

Vehicle (Roflumilast 0.3% vehicle cream)

Locations (1)

Rao Dermatology

Atlantic Highlands, New Jersey, United States